Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by University of Regensburg.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Technische Universität München
Information provided by:
University of Regensburg
ClinicalTrials.gov Identifier:
NCT01292278
First received: February 8, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
  Purpose

Neuropeptide Y (NPY) may play a major role in the pathophysiology of aneurysmal subarachnoid hemorrhage (aSAH). To investigate the correlation of NPY in cerebrospinal fluid (CSF) and blood (serum) and the neurological outcome in the acute stage of aSAH.


Condition
Subarachnoid Hemorrhage

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Possible Role of Neuropeptide Y After Spontaneous Subarachnoid Hemorrhage

Further study details as provided by University of Regensburg:

Biospecimen Retention:   Samples Without DNA

cerebrospinal fluid / serum


Estimated Enrollment: 90
Study Start Date: January 2006
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
aSAH
consecutive patients with spontaneous or aneurysmal subarachnoid hemorrhage
control group
no neurological disease but spinal anesthesia

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

consecutive pts. with subarachnoid hemorrhage

Criteria

Inclusion Criteria:

  • spontaneous or aneurysmal subarachnoid hemorrhage

Exclusion Criteria:

  • age younger than 18 years or older than 70 years
  • inflammatory disease
  • history of former SAH
  • no ventricular drainage
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01292278

Locations
Germany
Department of Neurosurgery Medical Center University of Regensburg Recruiting
Regensburg, Germany, 93053
Contact: Karl-Michael Schebesch, M.D.    ++49 +941 944 9010    karl-michael.schebesch@klinik.uni-regensburg.de   
Principal Investigator: Karl-Michael Schebesch, M.D.         
Sponsors and Collaborators
University of Regensburg
Technische Universität München
  More Information

No publications provided

Responsible Party: Alexander Brawanski M.D., Ph.D., University of Regensburg
ClinicalTrials.gov Identifier: NCT01292278     History of Changes
Other Study ID Numbers: CSF 06/179
Study First Received: February 8, 2011
Last Updated: February 8, 2011
Health Authority: Germany: The Bavarian State Ministry of the Environment and Public Health

Keywords provided by University of Regensburg:
subarachnoid hemorrhage
cerebral vasospasm
neuropeptide Y
spontaneous
aneurysmal

Additional relevant MeSH terms:
Hemorrhage
Subarachnoid Hemorrhage
Pathologic Processes
Intracranial Hemorrhages
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 01, 2014